Latest Growth Strategy News

SHAPE Australia Corporation Limited has reported a robust first half of FY26, with significant gains in revenue, profits, and project pipeline, underpinned by strategic sector diversification and a key acquisition.

SHAPE Australia Corporation Limited reported a robust half-year performance with a 48.5% rise in net profit and declared a fully franked 14 cent interim dividend, underpinned by strategic acquisition and operational discipline.

Australian Finance Group Ltd (AFG) has reported a record-breaking half-year profit for HY26, driven by strong broker network growth and improved funding terms that reduce cash rate sensitivity.

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Baby Bunting has reported record half-year sales and margin growth for 1H FY26, underpinned by its Store of the Future refurbishments and strategic expansions. The company maintains its full-year profit guidance while unveiling a new exclusive partnership with premium brand Stokke.

Smart Parking Limited has reported record first-half results for FY26, driven by strong organic growth and a successful US acquisition that boosted earnings per share by over 30%.

Judo Capital Holdings has delivered a robust 1H26 result, posting a 26% half-on-half profit before tax increase and upgrading its net interest margin guidance for the second half. The bank’s SME lending franchise continues to expand rapidly, supported by strong deposit growth and a solid capital position.

Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.

PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.